Chemokine level predicts the therapeutic effect of anti-PD-1 antibody (nivolumab) therapy for malignant melanoma

Nakamura, K; Ashida, A; Kiniwa, Y; Okuyama, R

Nakamura, K (通讯作者)，Shinshu Univ, Dept Dermatol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.

ARCHIVES OF DERMATOLOGICAL RESEARCH, 2022; 314 (9): 887

Abstract

Anti-programmed cell death protein 1 (PD-1) antibody drugs, nivolumab and pembrolizumab, are regarded as first-line therapies for advanced malignant m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索